Sunday, March 18, 2018

Precision cancer therapy works in 3/4 of patients, says study

/ 06:29 PM February 22, 2018
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Cancer, larotrectinib, Precision cancer therapy, tropomyosin receptor kinase fusions
For feedback, complaints, or inquiries, contact us.

© Copyright 1997-2018 | All Rights Reserved